Sonivate develops fingertip-mounted ultrasound devices (SonicEye) that attach to physicians' fingertips so users can continue using their hands while capturing ultrasound images. The SonicEye system streams live ultrasound to a Windows and Android app and is marketed as a lightweight, simple-to-operate solution for use cases such as military combat and field medics. The company expects to launch its SonicEye portable system in Q4 of this year and lists FDA clearance for the SonicEye probe as expected early next year. Financially, an SEC filing shows Sonivate has raised $1.4 million as part of a larger financing round, and the company previously received $8.7 million through SBIR and BAA programs. Sonivate was founded in 2001 and is based in Portland, Oregon. Leadership mentioned in reporting includes founder Dr. Ronald Schutz, CEO James Hatland, chairman Carl Anderson, and VP of engineering Bernard Mara. Sonivate Medical makes the SonicEye, an FDA-approved ultrasound probe designed to be worn on a clinician’s finger so doctors can use both hands while imaging. The device is positioned for applications including wound assessment and guided biopsies and is described as allowing clinicians to essentially “look through their finger.” The company partners with Japan-based Fukuda Denshi for distribution into the roughly $1.4 billion probe market. Sonivate was founded in 2001 and operates with a seven-person team in Beaverton, Ore. Financially, the startup has received $5.5 million in grants from the U.S. Army Medical and Material Research Command plus equity from angel investors, and plans to use fresh funding for sales and marketing.

Total raised

$2M

Funding rounds

2

Latest round

Equity

Latest activity

Nov 2019